Top Markets
#1 Gravity Gravity +68.84%
#2 Galxe Galxe +41.90%
#3 Aria.AI Aria.AI +26.39%
#4 Audiera Audiera +23.18%
#5 Velas Velas +23.15%
#6 Codatta Codatta +20.32%
#7 Pepe Pepe +18.90%
#8 Derive Derive +18.72%
#9 MemeCore MemeCore +15.75%
#10 Memetern Memetern +15.17%
Coin of the day
Gravity Gravity
設定
言語
日本
通貨
USD
テーマ
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated

VRTX
株式のランク #157
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in... Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients with CF 6 years of age or older who have at least one F508del mutation. Its pipeline includes VX-864 for the treatment of AAT deficiency, which is in Phase 2 clinical trial; VX-147 for the treatment of APOL1-mediated focal segmental glomerulosclerosis, or FSGS, and other serious kidney diseases which is in Phase 2 clinical trial; VX- 880, treatment for Type 1 Diabetes which is in Phase 1/2 clinical trial; VX-548, a NaV1.8 inhibitor for treatments of acute, neuropathic, musculoskeletal pain which is in Phase 2 clinical trial; and CTX001 for the treatment severe SCD and TDT which is in Phase 3 clinical trial. The company sells its products primarily to specialty pharmacy and specialty distributors in the United States, as well as specialty distributors and retail chains, and hospitals and clinics internationally. It has collaborations with Affinia Therapeutics, Inc.; Arbor Biotechnologies, Inc.; CRISPR Therapeutics AG.; Kymera Therapeutics, Inc.; Mammoth Biosciences, Inc.; Moderna, Inc.; Obsidian Therapeutics, Inc.; and Skyhawk Therapeutics, Inc.; as well as Ribometrix, Inc.; Genomics plc; Merck KGaA; Darmstadt, Germany, and X-Chem, Inc. Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Boston, Massachusetts.
株価
$469.34
時価総額
$119.21B
変化（1日）
-1.84%
変化（1年）
-7.87%
国
US
取引 Vertex Pharmaceuticals Incorporated (VRTX)

カテゴリー

Healthcare
時価総額
収益
もっと
利益
価格履歴
P/E比率
P/S比率
P/B比率
営業利益率
EPS
株式分割
配当金
配当利回り
発行済株式数
Vertex Pharmaceuticals Incorporated（VRTX）の株価履歴
終値の最高値: $476.90 （2026-03-01）

終値の最安値: $197.49 （2021-08-01）
Vertex Pharmaceuticals Incorporated の株価履歴（2021 ～ 2026）
年間株価パフォーマンス
年 パフォーマンス
2026 (TTM) -1.01%
2025 2.46%
2024 14.49%
2023 26.48%
2022 42.32%
2021 0.00%
類似企業または競合の株価
企業 株価 変化率 1年% 国
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 $37.96 -50.80%
DK
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 $745.77 11.83%
US
UCB SA UCB SA
UCB SA
UCB.BR
 $297.13 51.88%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $99.21 -36.97%
AU
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $700.45 15.78%
NL